Dr. Tripathy on the Development of Palbociclib in Breast Cancer

Article

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Recent Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Related Content
Illustration of breast.

Longer Duration of Adjuvant Trastuzumab May Further Improve DFS Rates in ERBB2-Positive Breast Cancer

Spencer Feldman
September 6th 2024
Article

Adjuvant trastuzumab reveals associations with improved disease-free survival in 1-year vs 9-week administration of the drug in patients with ERBB2-positive breast cancer.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Illustration of breast.

Patients With Breast Cancer May Have Increased Risk for Medication-Related Osteonecrosis of the Jaw

Spencer Feldman
August 28th 2024
Article

Compared with available literature, the rates of medication-related osteonecrosis of the jaw were higher in patients with breast cancer and bone metastases treated with antiresorptive therapy.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

AI May Predict Chronic Pain Risk in Patients With Breast Cancer

AI May Predict Chronic Pain Risk in Patients With Breast Cancer

Roman Fabbricatore
August 26th 2024
Article

A learning approach integrating time series and static data may improve understanding of breast cancer outcomes.

Breast Cancer Survivors May Not Undergo Genetic Testing, Counseling Regardless of Eligibility

Breast Cancer Survivors May Not Undergo Genetic Testing, Counseling Regardless of Eligibility

Roman Fabbricatore
August 16th 2024
Article

Genetic testing offers potential benefits after a cancer diagnosis by potentially reducing the risk for cancer in families with hereditary cancer syndromes and managing treatment.

© 2024 MJH Life Sciences

All rights reserved.